Skip to content

Preliminary study on the measurement accuracy and influencing factors of coronary functional FFROCT based on optical coherence tomography imaging system and disposable intravascular imaging catheter

Preliminary study on the measurement accuracy and influencing factors of coronary functional FFROCT based on optical coherence tomography imaging system and disposable intravascular imaging catheter

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500112355
Enrollment
Unknown
Registered
2025-11-12
Start date
2024-01-29
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

Gold Standard:Coronary flow reserve fraction measured by guidewire
Index test:Optical coherence tomography derived fractional flow fraction(FFR-OCT) measured by using the coronary artery OCT quantitative flow fraction calculation software based on optical coherence

Sponsors

The second hospital of Jilin university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 80 ; 2. Participants with stable or unstable angina pectoris; 3. Researchers believe that it is necessary and feasible to undergo angiography, and the results of the angiography need to be further diagnosed using OCT imaging and FFR measurement, then PCI if necessary; 4. Able to understand and voluntarily sign the informed consent form, and complete the observation as required.

Exclusion criteria

Exclusion criteria: 1. Participants with abnormal coagulation function tests that have clinical significance; 2. Participants with severe hemodynamic disorders or shock; 3. Those who have experienced acute myocardial infarction within the past week; 4. Having severe heart failure symptoms (NYHA class III or above) or left ventricular ejection fraction (LVEF) <30%; 5. Renal insufficiency (serum creatinine greater than 200µmol/L); 6. Participants who are not suitable for coronary angiography; 7. Those diagnosed with coronary artery spasm; 8. Diagnosed with chronic total occlusion of the coronary artery; 9. Severe calcification or tortuous lesions; 10. in stent restenosis ; 11. Those with a history of allergy to contrast agents or adenosine; 12. Pregnant or lactating women; 13. Participants in other clinical trials that have not yet reached the primary endpoint; 14. Researchers believe that participants who are not suitable for inclusion in this study.

Design outcomes

Primary

MeasureTime frame
Sensitivity;Specificity;

Secondary

MeasureTime frame
Accuracy;Negative Predictive Value;Negative predictive value;Positive likelihood ratio;Negative likelihood ratio;AUC of the ROC curve;Correlation between FFROCT (test device) and reference FFR;Agreement between FFROCT (test device) and reference FFR;Device handling performance;Adverse event rate;Device success rate;

Countries

China

Contacts

Public ContactLiu Bin

The Second Hospital of Jilin University

liubin3333@vip.sina.com+86 135 0081 0268

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026